Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNARF Regulatory News (NARF)

Share Price Information for NARF (NARF)

Share Price is delayed by 15 minutes
Get Live Data
0.475    -0.011 (-2.26%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £8.06m
NARF Live PriceLast checked at - London Stock Exchange

Intraday NARF Share Chart

$1.8m US Healthcare Cyber Security Contract

9 Oct 2023 07:00

RNS Number : 0517P
Narf Industries PLC
09 October 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

9 October 2023

NARF INDUSTRIES PLC

Awarded $1.8 Million US Healthcare Cyber Security Contract

Proactive Approach to Malware Risk in Electronic Health Records ("EHR")

Narf Industries plc ("Narf", the "Company", or the "Group"), (LSE: NARF) (OTCQB: NFIN.F) the cybersecurity group specializing in high-end threat intelligence and critical infrastructure security, is pleased to announce that it has been awarded a $1.8 million contract from the US Government's Advanced Research Projects Agency for Health (ARPA-H).

Under this contract awarded by ARPA-H, NARF will work on the Digital Health Security (DIGIHEALS[i]) programme titled "Electronic Health Record Format for Interoperable Secure Transformation (EHR-FIST)". This work leverages NARF's cutting-edge capabilities developed under its multi-million dollar SAFEDOC's contracts sponsored by another leading government agency, the Defense Advanced Research Project Agency ("DARPA").

The DIGIHEALS initiative supports innovative research that aims to protect the U.S. health care system's electronic infrastructure against hostile threats. SAFEDOCS has the same goal, but focused on standard business document formats, like PDFs. The complexities in these file format create opportunities for attackers to hide malicious code. In the case of DIGIHEALS, the hundreds of health care management software applications that process EHR are vulnerable to these advanced threats and put hospitals and patients at risk from ransomware and disruption of health services.

NARF is advancing innovative capabilities that detects malware risk buried deep within complex document structures before its launched and used by applications that can then infect critical infrastructure networks. Under these research agency funded contracts, NARF owns the intellectual property (IP) for commercial purposes and is constructing an array of disruptive advanced threat detection capabilities to form a next generation threat intelligence platform.

Dr. Michael Locasto, Director, NARF Government Research and Development (GR&D) Sector commented. "These research agencies rely on NARF's game changing approaches to keep pace with evolving threats. This is our inaugural contract with ARPA-H and we are now working to expand our relationships across the many other government and private research agencies involved in critical infrastructure security."

Steve Bassi, CEO of NARF commented: "It's the cumulative value and synergistic nature of these incremental research awards that's important to recognize in NARF's strategy to leverage non-dilutive research work into commercial products. Over 75% of this year's revenue, multi-million dollars, is directly contributing to our IP pipeline and creating the foundation for a new generation of threat intelligence and vulnerability solutions."

For further information on the Group please visit www.narfgroup.com or contact:

John Herring

NARF

jh@narfgroup.com

Catherine Leftley/Paul Dulieu /Isabel de Salis

St Brides Partners

narf@stbridespartners.co.uk

Peter Krens

Tennyson Securities

Tel: +44 (0)207 186 9030

About NARF Industries plc

Narf Industries (LSE: NARF)(OTCQB: NFIN.F) is a US based leading provider of cybersecurity research, solutions, and services to government entities. With a steadfast commitment to protecting national security and critical infrastructure, it offers comprehensive expertise in addressing the evolving cyber threats faced by its clients.

Narf works with various US government agencies including the Department of Defense ("DoD"), the Defense Advanced Research Projects Agency ("DARPA"), and the Department of Homeland Security ("DHS"). The Group often collaborates with world renowned private research companies and leading educational establishments in the performance of contracts.

Narf's strong track record of successful contract performance underscores its ability to deliver results. It understand the critical nature of the work performed by these agencies and the importance of maintaining the confidentiality and integrity of their missions.

With NARF's industry-leading expertise, advanced technologies, and unwavering commitment to excellence, it provides the US government with the confidence and peace of mind it needs to navigate the complex and ever-changing cybersecurity landscape.

The Group's strategy leverages government funded research and business to create and fund innovative and disruptive products for billion-dollar commercial cybersecurity markets and it has two key business areas:

Government Research and Development ("GR&D")

· The Group has a successful history of tendering for, and winning, government R&D contracts for groundbreaking technologies, predominantly from DARPA. Its research work is focused on three, multi-billion cybersecurity market segments: critical infrastructure protection; open-source software (OSS) vulnerabilities; and threat intelligence.

· For these contracts, the Government agency retains government purpose rights, but the Group has the sole right to sell new solutions using the intellectual property (IP) to the government (i.e., GS&S business). For commercial markets the Group owns the IP rights.

· The GR&D contracting process may range from 9 to 15 months and, once awarded, performance can range up to 18 months or longer. The Group projects stepped growth in its GR&D business targeting synergistic research areas that complement its current rich IP portfolio.

Government Solutions and Services ("GS&S")

· The Group develops solutions and performs services for various US government agencies. Its software solutions address immediate cybersecurity mission needs. These needs continually evolve as the nature of cybersecurity threats change, so it also provides on-going services supporting the operations of the delivered software solution.

· The Group enjoys a unique competitive position with GS&S work through a recently renewed 5-year omnibus contract. This streamlines government procurement cycles and gives multiple agencies access to the Group's solutions and services. Agencies execute task orders, many with awards justified on a sole source basis.

· The timing from ideation of task to award is 3 to 6 months. Tasks performance typically range from 6 to 12 months to complete, at which time software is delivered and integrated into an operational system.


[i] https://arpa-h.gov/engage/digiheals/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CNTFSFFAAEDSELS
12
Date   Source Headline
16th Apr 20267:00 amRNSTrading Update and New Contract Win
26th Mar 20267:00 amRNSInvestor Presentation
4th Dec 20257:00 amRNS$3.6m Contract Awarded by U.S. Government Agency
17th Nov 20257:00 amRNSInterim Results & Notice of Investor Presentation
2nd Oct 20252:37 pmRNSResult of AGM
4th Sep 20257:00 amRNSNotice of AGM
3rd Sep 20257:00 amRNSRanger.ai Secures DoD Marketplace Approval
31st Jul 20257:00 amRNSAudited Financial Results
24th Jul 20257:00 amRNSInvestor Presentation
27th Jun 20257:00 amRNSRanger open-source risk detection platform launch
20th Jun 20257:00 amRNSDirector's Loan Extension
4th Apr 20257:00 amRNSProgress update re: commercialization
6th Mar 20257:00 amRNSUS$6.8M Multi-Phase Contract with US Gov Agency
30th Dec 20247:00 amRNSInterim Results
7th Nov 20247:00 amRNSBusiness Update & Financial Guidance
4th Oct 202412:30 pmRNSResult of AGM
5th Sep 202412:00 pmRNSNotice of AGM
27th Aug 20247:00 amRNS$1.3m USAF Contract For AI-Powered Social Cyber
31st Jul 20247:00 amRNSFinal Results
12th Jun 20248:47 amRNSHolding(s) in Company
6th Jun 20247:00 amRNSOperational Update
1st May 20247:00 amRNSBreakthrough Threat Intel Capability Accelerated
8th Apr 20247:00 amRNSc.$500k contract win for US DOE Program
25th Mar 20247:00 amRNSNew Corporate Website
19th Mar 20247:01 amRNSHolding(s) in Company
19th Mar 20247:00 amRNSHolding(s) in Company
13th Mar 20247:00 amRNSHolding(s) in Company
12th Mar 20247:00 amRNSAwarded $1.3 Million Contract
1st Mar 202412:00 pmRNSInvestor Meet Company Presentation
22nd Feb 20242:58 pmRNSHolding(s) in Company
22nd Feb 20241:01 pmRNSResult of AGM
22nd Feb 20247:00 amRNSNew Task Order Awards of $1.6 million
19th Feb 20247:00 amRNSAppointment of Joint Broker
29th Jan 20245:23 pmRNSNotice of AGM
25th Jan 20247:00 amRNSCorporate Update
18th Dec 20237:00 amRNSCritical Infrastructure Collaboration
26th Oct 20237:00 amRNSKey New Executive Hire to Drive Growth in GS&S
9th Oct 20237:00 amRNS$1.8m US Healthcare Cyber Security Contract
5th Oct 20231:45 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSEMPLOYEE SHARE OPTION PLAN
4th Sep 20237:00 amRNSNew Task Order Awards of $1.2 million
14th Jul 20232:26 pmRNSLIFTING OF SUSPENSION
11th Jul 20232:46 pmRNSFinal Results
30th Jun 20237:00 amRNSTemporary Suspension Update
2nd May 20237:30 amRNSSuspension - Narf Industries Plc
26th Apr 20237:30 amRNSAppointment of Interim CFO
26th Apr 20237:00 amRNSAudit Update
24th Apr 20237:00 amRNSDirectorate Change
19th Apr 20231:14 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.